TAKE THE SURVEY - LET YOUR VOICE BE HEARD

WHAT IS THIS ABOUT?

The FDA has recently proposed regulating Lyme diagnostic tests.

This survey will be used by LymeDisease.org in its meetings with the FDA to show how this decision will impact patients.

IMPACT ON LYME PATIENTS

The types of lab tests the FDA wants to regulate include tests manufactured by the specialty labs that patients and doctors rely on for accurate tick-borne disease diagnosis.

Note: Current FDA-approved tests are shown to miss more than 50% of Lyme disease cases.

THE AMERICAN MEDICAL ASSOCIATION SAYS "NO"

TO NEW FDA REGULATIONS

These proposed changes are widely criticized. The AMA believes new regs will result in patients "losing access to timely life-saving diagnostic services and hinder advancements in the practice of medicine."

What do you think?

HELP US MAKE A DIFFERENCE.

Click Here - Take The Survey Now

For more information:

The FDA has announced it plans to severely restrict diagnostic testing for Lyme disease. Click here to learn more.

LymeDisease.org, publisher of The Lyme Times, advocates nationally for people with tick-borne diseases, educates the public and helps fund medical research. We are the go-to source for news, information and health policy analysis in the Lyme community. Become a member today.